There are 2949 resources available
842P - Carboplatin-induced thrombocytopenia in ovarian cancer: A focus on predictive factors
Presenter: Roberta Mazzeo
Session: E-Poster Display
Resources:
Abstract
843P - Association of gene expression signatures and TMB with response to pembrolizumab (pembro) in patients (pts) with recurrent ovarian cancer (ROC) enrolled in KEYNOTE-100
Presenter: Jonathan Ledermann
Session: E-Poster Display
Resources:
Abstract
844P - KRAS mutant epithelial ovarian carcinomas (EOC) represent distinct genomic genotypes
Presenter: Karolina Kilowski
Session: E-Poster Display
Resources:
Abstract
845P - Clinical utility of monitoring TP53 mutation (TP53m) circulating tumour DNA (ctDNA) in patients (pts) with high-grade ovarian carcinomas (HGOC)
Presenter: Maria Kfoury
Session: E-Poster Display
Resources:
Abstract
846P - DRDscore can predict platinum-resistance in advanced high-grade serous ovarian cancer
Presenter: Yuan Li
Session: E-Poster Display
Resources:
Abstract
847P - The prognostic value of chemosensitivity, estimated by the modeled CA-125 KELIM, in ovarian cancer patients treated with neo-adjuvant chemotherapy in the Netherlands
Presenter: Lilian Van Wagensveld
Session: E-Poster Display
Resources:
Abstract
848P - Features and clinical outcomes for younger women with epithelial ovarian cancer (EOC)
Presenter: Emeline Colomba-Blameble
Session: E-Poster Display
Resources:
Abstract
849P - Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer
Presenter: Synnöve Staff
Session: E-Poster Display
Resources:
Abstract
850P - Genetic factors contributing to the success rate of patient-derived xenograft revealed by genomic characterization in epithelial ovarian cancer
Presenter: Ying Shan
Session: E-Poster Display
Resources:
Abstract
851P - PLA2G7/PAF-AH as protective factor and potential negative regulator of the Wnt signaling pathway in BRCA1 mutant ovarian cancer
Presenter: Yue Liao
Session: E-Poster Display
Resources:
Abstract